Cardiovascular Risk Management: BIO-RISK-EVENT Study

We are testing a new approach to managing heart health in patients at high risk for heart events. The goal is to see if this intensified treatment is more effective than standard care.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Empaglifozin
Empaglifozin is a medicine that helps lower blood sugar in adults with type 2 diabetes and can reduce the risk of heart-related problems.
Vazkepa
Vazkepa is a medicine used to help reduce the risk of heart problems in adults with high blood triglyceride levels.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Colchicine
Colchicine is a substance that reduces inflammation to treat and prevent gout attacks.
Empagliflozin
Empagliflozin is a substance that helps lower blood sugar in people with type 2 diabetes by increasing sugar removal in the urine.
Icosapent Ethyl
Icosapent ethyl is a substance that lowers very high blood triglyceride levels to help reduce heart disease risk.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Empagliflozin Krka
Empagliflozin Polpharma
Empelic

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Kardinal Schwarzenberg Klinikum GmbH
Department of Internal Medicine 1
Bischofshofen, Austria
Vivit Institute
Department of Internal Medicine
Feldkirch, Austria
Bezirkskrankenhaus St. Johann
Department of Internal Medicine
Graz, Austria

Sponsor: Medical University Of Graz
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.